Rhumbline Advisers Emergent Bio Solutions Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 84,025 shares of EBS stock, worth $748,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,025
Previous 8,731
862.38%
Holding current value
$748,662
Previous $42,000
1176.19%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding EBS
# of Institutions
184Shares Held
41.1MCall Options Held
143KPut Options Held
168K-
Black Rock Inc. New York, NY3.84MShares$34.2 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$32.2 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$31.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$22.3 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.4 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $444M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...